AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue of how some of the largest pharmaceutical companies are reaching patients worldwide, especially in low- and middle-income countries (LMICs). Ahead of the 2024 Access to Medicine
AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) — The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue of how some of the largest pharmaceutical companies are reaching patients worldwide, especially in low- and middle-income countries (LMICs). Ahead of the 2024 Access to Medicine
AMSTERDAM, 10 sept. 2024 (GLOBE NEWSWIRE) — Le dernier rapport de l’Access to Medicine Foundation se penche pour la première fois sur la question cruciale de l’approche de certaines des plus grandes entreprises pharmaceutiques visant à améliorer l’accès aux médicaments pour les patients dans le monde entier, en particulier dans
AMSTERDAM, 10 sept. 2024 (GLOBE NEWSWIRE) — Le dernier rapport de l’Access to Medicine Foundation se penche pour la première fois sur la question cruciale de l’approche de certaines des plus grandes entreprises pharmaceutiques visant à améliorer l’accès aux médicaments pour les patients dans le monde entier, en particulier dans
LONDON, Sept. 10, 2024 (GLOBE NEWSWIRE) — AI-Media, the global leader in AI-powered captioning and translation services, is proud to announce a new partnership with ITV, the UK’s largest commercial broadcaster. This collaboration marks a significant step forward in the use of AI captioning technology to enhance accessibility and operational
LONDON, Sept. 10, 2024 (GLOBE NEWSWIRE) — AI-Media, the global leader in AI-powered captioning and translation services, is proud to announce a new partnership with ITV, the UK’s largest commercial broadcaster. This collaboration marks a significant step forward in the use of AI captioning technology to enhance accessibility and operational
